Cargando…
Pharmaceutical Therapies for Necroptosis in Myocardial Ischemia–Reperfusion Injury
Cardiovascular disease morbidity/mortality are increasing due to an aging population and the rising prevalence of diabetes and obesity. Therefore, innovative cardioprotective measures are required to reduce cardiovascular disease morbidity/mortality. The role of necroptosis in myocardial ischemia–re...
Autores principales: | Zhang, Yinchang, Zhang, Yantao, Zang, Jinlong, Li, Yongnan, Wu, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380972/ https://www.ncbi.nlm.nih.gov/pubmed/37504559 http://dx.doi.org/10.3390/jcdd10070303 |
Ejemplares similares
-
Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023) -
Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms
por: Jia, Jun-ying, et al.
Publicado: (2020) -
Ginsenoside Rg2 Ameliorates Myocardial Ischemia/Reperfusion Injury by Regulating TAK1 to Inhibit Necroptosis
por: Li, Yao, et al.
Publicado: (2022) -
Comprehensive analysis of necroptosis-related genes in renal ischemia-reperfusion injury
por: Li, Shuai, et al.
Publicado: (2023) -
CHIP ameliorates cerebral ischemia-reperfusion injury by attenuating necroptosis and inflammation
por: Yao, Dabao, et al.
Publicado: (2021)